Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma
Status:
RECRUITING
Trial end date:
2031-02-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects (good and bad) that Tebentafusp in combination with Yttrium-90 (Y-90) radioembolization has on patients with metastatic uveal melanoma that has spread to the liver.